Waterways Leisure Tourism IPO Day 3: Issue subscribed 69%, GMP signals flat debut. Should you apply?Waterways Leisure Tourism IPO: The IPO received a lukewarm response on its final day of bidding, with the issue subscribed only 69% overall...
25 Jun, 2026, 12.18 PM IST
CSM Technologies IPO Day 2 update: Subscribed 32%, GMP at 4%. Should you subscribe?CSM Technologies' IPO is seeing a subdued response on its second day, with only 32% subscription. Retail investors show more interest, subs...
25 Jun, 2026, 11.08 AM IST
Advit Jewels IPO Day 2: Issue subscribed over 20x, GMP signals 41% listing gains. Should you bid?Jaipur-based Advit Jewels' IPO is seeing massive investor interest, subscribed over 20 times on day two with a strong grey market premium. ...
24 Jun, 2026, 11.48 AM IST
Leapfrog Engineering shares list at 4.3% discount from IPO price on BSE SMELeapfrog Engineering Services experienced a subdued market entry, with its shares listing at a 4.3% discount to the IPO price on the BSE SM...
24 Jun, 2026, 10.47 AM IST
CSM Technologies IPO opens: Check brokerage review, GMP and other detailsThe IPO will remain open until June 26. It is a book-built issue with a price band of Rs 147-155 per share. The issue comprises a fresh iss...
24 Jun, 2026, 10.08 AM IST
Waterways Leisure Tourism IPO Day 2: GMP signals flat debut - Should you apply?Waterways Leisure Tourism IPO entered Day 2 with weak investor demand and a GMP of around 1%, signalling a flat listing outlook. Subscripti...
24 Jun, 2026, 09.30 AM IST
US Stocks Today | Chip stocks plunge, but bargain-hunters stem losses in other tech namesUS chip stocks experienced a significant tumble, impacting the broader market and wiping out billions in value. While tech giants like Nvid...
23 Jun, 2026, 08.29 PM IST
Ben Lamm and Colossal Biosciences: The billionaire tech founder behind the $10 billion plan to bring back extinct animalsTech entrepreneur Ben Lamm is spearheading Colossal Biosciences, a company aiming to bring back extinct species like the woolly mammoth thr...
23 Jun, 2026, 07.40 PM IST
Turtlemint Fintech IPO Day 3: Fully subscribed 1.02x, GMP signals, brokerage views and key detailsTurtlemint Fintech's IPO saw strong demand, fully subscribing on its final day with institutional investors showing significant interest. D...
23 Jun, 2026, 03.37 PM IST
Advit Jewels IPO booked over 6.5x on Day 1 so far; all categories oversubscribed; GMP signals 47% listing gainsJaipur's Advit Jewels is experiencing a robust IPO debut, with investor demand surging on day one, leading to a 6.75 times subscription. Th...
23 Jun, 2026, 02.13 PM IST
Waterways Leisure Tourism IPO sees a slow response on Day 1 so far. Should you subscribe?Waterways Leisure Tourism’s IPO opened to a muted response, with subscription at 7% on Day 1 and weak institutional participation. While th...
23 Jun, 2026, 01.05 PM IST
US stocks: S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on IranUS market saw a mixed close as the S&P 500 and Nasdaq dipped, primarily due to tech giants like Alphabet facing investor scrutiny over AI s...
23 Jun, 2026, 01.54 AM IST
SpaceX holds $100.8 billion in cash as Elon Musk's rockets-to-AI reveals major details after $75 billion IPO makes it one of world's most valuable companiesSpaceX shares jumped 19 per cent in their Nasdaq debut on June 12, when it raised more than $75 billion in a record offering.
22 Jun, 2026, 06.52 PM IST
Turtlemint Fintech IPO Day 2: Issue subscribed 52%; Check GMP and other key detailsTurtlemint Fintech Solutions IPO: The issue, comprising a fresh issue of ₹660.7 crore and an offer-for-sale of ₹221.9 crore, is priced at ₹...
22 Jun, 2026, 05.20 PM IST
Two Trades for Today: A maker of forged components for a 7.7% gain, a mid-cap pharma stock for a 6% upmoveOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
11 Jun, 2026, 12.31 PM IST
Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...
10 Jun, 2026, 01.11 PM IST
Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspensionConcord Biotech shares saw a significant jump on Wednesday. This surge followed the company's announcement of receiving approval from the U...
03 Jun, 2026, 11.39 AM IST